0001127602-15-010336.txt : 20150305 0001127602-15-010336.hdr.sgml : 20150305 20150305172939 ACCESSION NUMBER: 0001127602-15-010336 CONFORMED SUBMISSION TYPE: 4 PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20150303 FILED AS OF DATE: 20150305 DATE AS OF CHANGE: 20150305 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: Alkermes plc. CENTRAL INDEX KEY: 0001520262 STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834] IRS NUMBER: 981007018 FISCAL YEAR END: 1231 BUSINESS ADDRESS: STREET 1: CONNAUGHT HOUSE STREET 2: 1 BURLINGTON ROAD CITY: DUBLIN 4 STATE: L2 ZIP: 00000 BUSINESS PHONE: 00-353-1-772-8000 MAIL ADDRESS: STREET 1: CONNAUGHT HOUSE STREET 2: 1 BURLINGTON ROAD CITY: DUBLIN 4 STATE: L2 ZIP: 00000 FORMER COMPANY: FORMER CONFORMED NAME: ANTLER SCIENCE TWO PLC DATE OF NAME CHANGE: 20110804 FORMER COMPANY: FORMER CONFORMED NAME: Antler Science Two Ltd DATE OF NAME CHANGE: 20110509 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: Peterson Rebecca CENTRAL INDEX KEY: 0001555260 FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 001-35299 FILM NUMBER: 15678477 MAIL ADDRESS: STREET 1: 90 ROBBINS ROAD CITY: WATERTOWN STATE: MA ZIP: 02472 4 1 form4.xml PRIMARY DOCUMENT X0306 4 2015-03-03 0001520262 Alkermes plc. ALKS 0001555260 Peterson Rebecca 852 WINTER ST. WALTHAM MA 02451 1 SVP, Corporate Communications Ordinary Shares 2015-03-03 4 M 0 15375 47.16 A 15375 D Ordinary Shares 2015-03-03 4 S 0 14600 71.27 D 775 D Ordinary Shares 2015-03-03 4 S 0 775 72.0387 D 0 D Ordinary Shares 2015-03-03 4 M 0 3500 0 A 3500 D Ordinary Shares 2015-03-03 4 F 0 1138 72.80 D 2362 D Ordinary Shares 2015-03-05 4 S 0 2362 71.8019 D 0 D Employee Stock Option (Right to Buy) 47.16 2015-03-03 4 M 0 15375 0 D 2015-03-03 2024-03-03 Ordinary Shares 15375 46125 D Restricted Stock Unit Award 0 2015-03-03 4 M 0 3500 0 D 2015-03-03 Ordinary Shares 3500 10500 D This option exercise was effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person. This sale was effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person. The price reported in Column 4 is a weighted average price. The shares were sold in multiple transactions at prices ranging from $70.82 to $71.75. Full information regarding the number of shares sold at each separate price can be furnished to the SEC staff upon request. The price reported in Column 4 is a weighted average price. The shares were sold in multiple transactions at prices ranging from $71.82 to $72.18. Full information regarding the number of shares sold at each separate price can be furnished to the SEC staff upon request. The price reported in Column 4 is a weighted average price. The shares were sold in multiple transactions at prices ranging from $71.36 to $72.1264. Full information regarding the number of shares sold at each separate price can be furnished to the SEC staff upon request. Shares subject to the stock option award vest in four equal annual installments commencing on 3/3/15. Shares subject to the restricted stock unit award vest in equal annual installments over a four year period, commencing 3/3/2015. /s/ Jennifer Baptiste, attorney-in-fact for Rebecca Peterson 2015-03-05